205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.35%
Negative revenue growth while NXPI stands at 3.21%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-2.35%
Negative gross profit growth while NXPI is at 0.13%. Joel Greenblatt would examine cost competitiveness or demand decline.
-9.39%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-9.39%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
0.85%
Positive net income growth while NXPI is negative. John Neff might see a big relative performance advantage.
-3.57%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-3.57%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-4.27%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-4.27%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
1.64%
Dividend growth above 1.5x NXPI's 0.12%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
133.53%
OCF growth above 1.5x NXPI's 37.88%. David Dodd would confirm a clear edge in underlying cash generation.
2372.73%
FCF growth above 1.5x NXPI's 94.26%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-12.84%
Negative 10Y revenue/share CAGR while NXPI stands at 79.10%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
44.05%
5Y revenue/share CAGR at 50-75% of NXPI's 77.31%. Martin Whitman would worry about a lagging mid-term growth trajectory.
27.18%
Positive 3Y CAGR while NXPI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
90.99%
10Y OCF/share CAGR at 75-90% of NXPI's 104.58%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
16.19%
Below 50% of NXPI's 107.18%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
160.94%
Positive 3Y OCF/share CAGR while NXPI is negative. John Neff might see a big short-term edge in operational efficiency.
-16.62%
Negative 10Y net income/share CAGR while NXPI is at 36.73%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-293.74%
Negative 5Y net income/share CAGR while NXPI is 328.95%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-187.06%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
419.26%
Below 50% of NXPI's 1254.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
175.56%
5Y equity/share CAGR above 1.5x NXPI's 18.89%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
158.15%
3Y equity/share CAGR above 1.5x NXPI's 42.98%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
28.19%
Dividend/share CAGR of 28.19% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
6.92%
Below 50% of NXPI's 169.49%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
54.74%
3Y dividend/share CAGR above 1.5x NXPI's 20.43%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-17.32%
Firm’s AR is declining while NXPI shows 1.04%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-16.56%
Inventory is declining while NXPI stands at 0.47%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.51%
Asset growth above 1.5x NXPI's 0.28%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
7.46%
BV/share growth above 1.5x NXPI's 3.20%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-1.19%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
6.70%
R&D growth drastically higher vs. NXPI's 4.75%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-3.53%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.